EORTC Completes Patient Recruitment to Study of Treatment for Rare Cancer High-Grade Uterine Sarcoma
18 Oct 2021
New results from immunotherapy trials from the EORTC gynaecological and lung cancer groups presented at ESMO 2021
20 Sep 2021
View our webinar “Clinical Trials: the patient in academic studies” (September 15, 2021)
16 Sep 2021
News from the ESTRO 2021 congress: EORTC-ESTRO RADiation Infrastructure for Europe (E2-RADIatE) OligoCare trial assesses real-world patterns of practice of radical radiotherapy for oligometastatic disease
28 Aug 2021
News from the ESTRO 2021 congress: Denis Lacombe, awarded honorary membership of ESTRO, emphasises the importance of radiation oncology in multidisciplinary research
28 Aug 2021
Combined hormone/radiotherapy treatment improves event-free and disease-free survival in patients with localised intermediate risk prostate cancer; long-term results from EORTC Trial 22991
30 Jul 2021
EORTC 1634-Brain Tumour Group trial in Post-Pubertal Patients with Newly-Diagnosed Medulloblastoma (PersoMed-I) receives support from Gateway for Cancer Research℠
27 Jul 2021
PRESS RELEASE: European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre Partner to Address Treatment Gap for Stage 2 Melanoma Patients
29 Jun 2021
